To evaluate the efficacy of conventional CD19‐targeting monoclonal antibodies in autoimmunity diseases, we generated a mouse anti‐mouse CD19 IgG1 and investigated its in vivo effect using the spontaneous lupus‐prone murine models, MRL/lpr mice, for further investigation. Here, CD19 is linked to Autoimmunity.